Showing results (171-180 of 193) with videos related to
Sort By:
Pageof 20
International Journal of Cancer|October 16, 2010
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccineKevin A Ault, Elmar A Joura, Susanne K Kjaer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.Human Vaccines & Immunotherapeutics|February 3, 2025
Acceptance and attitudes towards COVID-19 vaccination during pregnancy in CanadaSuraya Bondy, Elisabeth McClymont, Gal Av-Gay, et al.JAMA|May 2, 2022
Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal OutcomesElisabeth McClymont, Arianne Y Albert, Gillian D Alton, et al.CMAJ Open|April 4, 2023
Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence studyAndrea Atkinson, Arianne Albert, Elisabeth McClymont, et al.International Journal of Cancer|December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE studyS Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.Cancer Medicine|July 6, 2019
Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodiesDominique Rosillon, Laurence Baril, Maria Rowena Del Rosario-Raymundo, et al.Vaccine|November 16, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.Pageof 20